Rock, Brooke M.
Amgen (United States)
3 papers on CoChatORCID 0000-0002-2973-824X
Most cited papers
- Verified
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Koren, M. J., Moriarty, P. M., Baum, S. J., Neutel, J., Hernandez-Illas, M., Weintraub, H. S., Florio, M., Kassahun, H., Melquist, S., Varrieur, T., et al. (2022) · Nature Medicine
Lipoproteins and Cardiovascular HealthRNA Interference and Gene Delivery
Cited by 239
- Verified
Intact mass analysis of monoclonal antibodies by capillary electrophoresis—Mass spectrometry
Han, M., Rock, B. M., Pearson, J. T., & Rock, D. A. (2016) · Journal of Chromatography B
Mass Spectrometry Techniques and ApplicationsBiosimilars and Bioanalytical Methods
Cited by 82
- Verified
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs
Bai, N., Riching, K. M., Makaju, A., Wu, H., Acker, T. M., Ou, S.-C., Zhang, Y., Shen, X., Bulloch, D. N., Rui, H., et al. (2022) · Journal of Biological Chemistry
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free